Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSDT)

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,171
  • Shares Outstanding, K 51,682
  • Annual Sales, $ 1,500 K
  • Annual Income, $ -9,780 K
  • 60-Month Beta 0.78
  • Price/Sales 13.81
  • Price/Cash Flow N/A
  • Price/Book 6.31
Trade HSDT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.50
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +57.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3600 +10.72%
on 11/04/20
0.4400 -9.41%
on 11/11/20
-0.0211 (-5.03%)
since 10/27/20
3-Month
0.3600 +10.72%
on 11/04/20
0.5350 -25.50%
on 09/01/20
-0.0882 (-18.12%)
since 08/27/20
52-Week
0.2490 +60.08%
on 04/08/20
1.4900 -73.25%
on 12/26/19
-0.0314 (-7.30%)
since 11/27/19

Most Recent Stories

More News
Sidoti Virtual Microcap Investor Conference

Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for today's Virtual Microcap Investor Conference.

CMI.VN : 2.610 (-4.04%)
YTRA : 1.7100 (+13.25%)
ASC : 3.47 (-1.42%)
MTBC : 10.60 (+0.76%)
TNXP : 0.5720 (+3.62%)
III : 3.19 (+8.87%)
WLMS : 1.7700 (unch)
HSDT : 0.3986 (+2.13%)
CVGI : 7.29 (+1.25%)
ALCO : 32.15 (+0.47%)
AP : 4.31 (-1.15%)
AFI : 3.80 (+6.74%)
BELFB : 15.16 (-1.30%)
JRSH : 5.37 (+2.27%)
Helius Medical Technologies, Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies to Present at the virtual Fall Investor Summit on November 16th-18th

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Helius Medical Technologies (NASDAQ:HSDT), will be presenting at this year's virtual Fall Investor Summit on November 16th-18th.

HSDT : 0.3986 (+2.13%)
Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the following...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment(TM) Clinic Locations Across Canada

Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that the Company has expanded its authorized...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies to Release Third Quarter of Fiscal Year 2020 Financial Results on November 12, 2020

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that third quarter of fiscal year 2020 financial...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies Announces Closing of $3.4 Million Private Placement

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today that it has closed its previously announced...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies Announces $3.4 Million Private Placement

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today that it has entered into a securities purchase...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies, Inc. Provides Update on FDA's Review of its Request for De Novo Classification and Clearance of the PoNS(TM) Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has received a request for additional...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)
Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights

Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced a partnership with Breakthrough Health ("Breakthrough"),...

HSDT : 0.3986 (+2.13%)
HSM.TO : 0.51 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

2nd Resistance Point 0.4101
1st Resistance Point 0.4044
Last Price 0.3986
1st Support Level 0.3885
2nd Support Level 0.3783

See More

52-Week High 1.4900
Fibonacci 61.8% 1.0159
Fibonacci 50% 0.8695
Fibonacci 38.2% 0.7231
Last Price 0.3986
52-Week Low 0.2490

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar